Re-appraising the use of Faecal calprotectin sample (FC)

Faecal calprotectin (FC) serves as a recognized marker of inflammation, consistently displaying elevated levels in the stool of patients with inflammatory bowel disease (IBD) compared to control groups. Its utilization is endorsed by NICE for patients presenting with new-onset lower gastrointestinal symptoms.  Through this research endeavor will contribute to refining referral pathways, especially concerning cases with borderline elevated results.

Find out more: Re-appraising the use of Faecal calprotectin sample (FC) | Central London Healthcare